Impact of a patent foramen ovale (PFO) presence in patients with GOLD stage II chronic obstructive pulmonary disease (COPD)
D. Martolini, R. Tanner, D. Shrikrishna, C. Davey, C. Smith, M. Patel, Z. Zoumot, A. Donaldson, D. Mohan, G. Coissi, S. Clark, D. Elia, P. Palange, N. Hopkinson, M. I. Polkey (London, United Kingdom; Rome, Italy)
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Martolini, R. Tanner, D. Shrikrishna, C. Davey, C. Smith, M. Patel, Z. Zoumot, A. Donaldson, D. Mohan, G. Coissi, S. Clark, D. Elia, P. Palange, N. Hopkinson, M. I. Polkey (London, United Kingdom; Rome, Italy). Impact of a patent foramen ovale (PFO) presence in patients with GOLD stage II chronic obstructive pulmonary disease (COPD). Eur Respir J 2012; 40: Suppl. 56, 250
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: